Alpha-lipoic acid – a proper choice for the treatment of diabetic neuropathy?
The authors reviewed the results of international and Russian studies of oral and intravenous alpha-lipoic acidin diabetic polyneuropathy patients. According to the randomized controlled data, alpha-lipoic acid was the only pathogenetically active agent with proved efficacy in diabetic polyneuropathy (evidence level A).